Technical Analysis for ACUR - Acura Pharmaceuticals, Inc.

Grade Last Price % Change $ Change
grade D $0.58 0.00% 0.0
ACUR closed unchanged on Friday, March 24, 2017, on 2 percent of normal volume.
Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical ACUR trend table...

Date Alert Name Type % Chg
Mar 24 Narrow Range Bar Range Contraction 0.00%
Mar 24 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Mar 23 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Mar 22 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Mar 21 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 16.00%
Mar 20 Narrow Range Bar Range Contraction 1.75%
Mar 20 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 1.75%
Mar 17 Narrow Range Bar Range Contraction 1.75%
Mar 17 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 1.75%
Mar 16 Shooting Star Candlestick Bearish 5.45%

Older signals for ACUR ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Basic chart:

Profile
Acura Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and commercialization of product candidates intended to address medication abuse and misuse utilizing its proprietary Aversion and Impede technologies. Its products include Oxecta Tablets CII, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed, an over-the-counter immediate-release pseudoephedrine HCl tablet that is used as a nasal decongestant in various non-prescription and prescription cold, sinus, and allergy products. The company has seven additional opioid products utilizing Aversion technology in various stages of development. Acura Pharmaceuticals, Inc. has a license, development, and commercialization agreement with King Pharmaceuticals Research and Development, Inc., a wholly-owned subsidiary of Pfizer Inc. to develop and commercialize certain opioid analgesic products utilizing the company’s proprietary Aversion technology in the United States, Canada, and Mexico. The company was founded in 1935 and is based in Palatine, Illinois.
Is ACUR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 3.52
52 Week Low 0.46
Average Volume 652,209
200-Day Moving Average 1.2383
50-Day Moving Average 0.6512
20-Day Moving Average 0.5345
10-Day Moving Average 0.552
Average True Range 0.0871
ADX 13.76
+DI 18.75
-DI: 15.63
Chandelier Exit (Long, 3 ATRs) 0.4887
Chandelier Exit (Short, 3 ATRs) 0.7213
Upper Bollinger Band 0.596
Lower Bollinger Band 0.473
Percent B (%b) 0.87
Bandwidth 0.230122